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The current circulating swine influenza virus (IV) subtypes in Europe (H1N1, H1N2, and 
H3N2) are associated with clinical outbreaks of disease. However, we showed that pigs 
could be susceptible to other IV strains that are able to cross the species barrier. In this 
work, we extended our investigations into whether different IV strains able to cross the 
species barrier might give rise to different innate immune responses that could be asso-
ciated with pathological lesions. For this purpose, we used the same samples collected 
in a previous study of ours, in which healthy pigs had been infected with a H3N2 Swine 
IV and four different H3N8 IV strains circulating in different animal species. Pigs had 
been clinically inspected and four subjects/group were sacrificed at 3, 6, and 21 days 
post infection. In the present study, all groups but mock exhibited antibody responses 
to IV nucleoprotein protein. Pulmonary lesions and high-titered viral replication were 
observed in pigs infected with the swine-adapted virus. Interestingly, pigs infected with 
avian and seal H3N8 strains also showed moderate lesions and viral replication, whereas 
equine and canine IVs did not cause overt pathological signs, and replication was barely 
detectable. Swine IV infection induced interferon (IFN)-alpha and interleukin-6 responses 
in bronchoalveolar fluids (BALF) at day 3 post infection, as opposed to the other non-
swine-adapted virus strains. However, IFN-alpha responses to the swine-adapted virus 
were not associated with an increase of the local, constitutive expression of IFN-alpha 
genes. Remarkably, the Equine strain gave rise to a Serum Amyloid A response in BALF 
despite little if any replication. Each virus strain could be associated with expression of 
cytokine genes and/or proteins after infection. These responses were observed well 
beyond the period of virus replication, suggesting a prolonged homeostatic imbalance 
of the innate immune system.
Keywords: pig, influenza, virus, innate immunity, cytokines
Abbreviations: FCS, fetal calf serum; PCR, polymerase chain reaction; OD, optical density; ODNs, oligodeoxynucleotides; PBS, 
phosphate buffered saline; RT, reverse transcription; TcR, T cell receptor.
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inTrODUcTiOn
The first line of defense after viral infections is based on innate 
immunity, which has the capacity to respond to pathogens 
by sensing pathogen-associated molecular patterns (PAMPs) 
through germline-encoded pattern recognition receptors. This 
process leads to the production of several cytokines such as 
type I (α and β) interferons (IFNs). These bind to the type I 
IFN receptor to signal the induction of hundreds of interferon-
stimulated genes in the local uninfected and virus-infected cells, 
thus creating an antiviral state that suppresses virus infection 
and serves to promote the onset of adaptive immunity (1, 2). 
Innate immune responses are crucial not only for blunting viral 
replication in the first instance but also for orchestrating effective 
adaptive immune responses. Therefore, a transient induction 
of cytokines and chemokines is required for efficient antiviral 
responses. However, overreacting and prolonged immune 
responses may lead to undesired secondary effects, contributing 
to immunopathology.
As for influenza virus (IV), the innate immune response may 
vary between mild and severe infections, and include widely 
different soluble innate immune inhibitors: sialic acid-based 
inhibitors, Ca-dependent lectin inhibitors, anti-microbial pep-
tides, complement, natural IgM, IFNs, to name a few (3). Toll-like 
receptors 3 and 7 (TLR-3 and TLR-7) have been found to play an 
important role in influenza A virus recognition and initiation of 
the immune response in human respiratory epithelial cells and 
plasmacytoid dendritic cells (pDCs) (4). Activation of both TLRs 
and cytoplasmic receptors leads to a potent type I IFN release 
and simultaneous pro-inflammatory cytokine expression. Type 
I IFNs, IFN-γ, and pro-inflammatory cytokines, such as inter-
leukin (IL)-1, IL-6, IL-8, IL-12, and tumor necrosis factor-alpha 
(TNF-α), have been shown to be upregulated in lung tissue and 
lung lavage after experimental infection of pigs with Swine IV 
(5–7).
Three IV subtypes (H1N1, H1N2, and H3N2) are currently 
circulating in swine herds in Europe (8–10) and have been asso-
ciated with disease occurrence and gross lesions in swine (11). 
Also, pigs are susceptible to infection with low pathogenic and 
highly pathogenic avian IVs (LPAIV and HPAIV, respectively) 
(12). Most LPAIV subtypes diagnosed in field samples possess 
a H1 or H3 hemagglutinin usually restricted to birds. HPAIV 
are able to infect pigs under natural and experimental condi-
tions (12). Besides, it is well known that some IVs are able to 
infect humans and pigs, as it was the case in the last H1N1 2009 
pandemic infection (13, 14). In vitro, different IV strains can 
interact with porcine dendritic cells (DCs) and induce sequen-
tial waves of cytokine production that are dependent on time 
and virus strain (15). This effect could account for the different 
immune responses generated by IV strains. On the other hand, 
we have previously examined the potential of H3N8 IV from 
canine, equine, avian, and seal origin to productively infect pigs. 
Our results demonstrated that avian and seal viruses replicated 
substantially and caused detectable lesions in inoculated pigs 
without previous adaptation (16). However, no studies in  vivo 
have addressed whether innate immune responses of pigs to 
swine-adapted and non-adapted IV strains might be different. 
The above findings outline the main working hypothesis of our 
study, which implies that Swine IV strains might give rise to 
peculiar innate immune responses and time courses thereof in 
pigs, clearly different from those triggered by other IV strains. In 
order to answer these questions, samples from pigs infected with 
a Swine (H3N2) and four different non-swine-adapted H3N8 
IV strains circulating in different animal species (dogs, horses, 
wild aquatic birds, and seals) from our previous study (16) were 
analyzed and innate immune responses in the respiratory tract 
were thoroughly investigated.
aniMals anD MeThODs
animals
In line with the above operational framework, six groups of pigs 
(7–8 weeks old, Landrace × Pietrain, free from common patho-
gens) were housed in separate isolation rooms and adapted to 
the new environment and stockmen over a 1-week period under 
veterinary supervision. The animals used in our study were 
seronegative at that time to Influenza A viruses by competition 
Elisa (ID Screen® Influenza A Antibody Competition ELISA, 
ID-Vet, France). Also, they had been always healthy and thrifty 
before the present study.
experimental infection
The experimental infection of pigs with different IV strains was 
described in our previous paper (16).
Pigs were infected with the following IV strains:
Group 1: 6 pigs, mock-infected.
Group 2: 12 pigs. A/swine/Spain/54008/2004 (H3N2), a Swine 
IV strain.
Group 3: 12 pigs. A/equine/OH/1/03 (H3N8), an Equine IV 
strain.
Group 4: 12 pigs. A/canine/NY/105447/08 (H3N8), a Canine IV 
strain.
Group 5: 12 pigs. A/American black duck/Maine/44411-532/2008 
(H3N8), an Avian IV strain.
Group 6: 12 pigs. A/Harbor Seal/New Hampshire/179629/2011 
(H3N8), a Seal IV strain.
At day 0, each pig in groups 2, 3, 4, 5, and 6 was intratrache-
ally infected with 1  ml of virus suspension in PBS, containing 
2 ×  105 Chicken Embryo Infectious Doses 50% (EID50) of the 
corresponding virus strain. Animals were clinically inspected 
on a daily basis. Rectal temperature and weight were measured 
at the same times. Four pigs of each virus-infected group were 
euthanized at day 3, 6, and 21 post infection (p.i.), respectively. 
In the mock-infected group, two pigs were euthanized at each of 
the same times.
samplings and Postmortem examination
Blood serum samples in vacuum tubes were collected from 
jugular veins at day 0 and just before sacrifice at the aforemen-
tioned days. After sacrifice, bronchoalveolar fluids (BALF) were 
collected by lung lavage with PBS, as described by Busquets 
et al. (14). Briefly, the right lung of sacrificed pigs was used to 
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perform a bronchoalveolar lavage (BAL) using around 100  ml 
of PBS, and the left one was sampled for histopathological and 
virological studies. A complete necropsy was performed. Lung 
lesions were classified depending on the extent of pneumonia. 
Mild lesions were recorded when affecting small areas (<2 cm2) 
of cranial or medial lung lobes, moderate lesions when affecting 
extended areas (2–5 cm2) of cranial or medial lobes, and severe 
lesions when affecting large areas (>5  cm2) of cranial, medial, 
diaphragmatic, and accessory lobes.
histopathology
Samples from nasal turbinates, trachea, and lungs were collected, 
fixed in 10% buffered formalin and processed for histopathology, 
i.e., they were dehydrated through graded alcohols and embed-
ded in paraffin. The 3-µm thick sections were cut, stained with 
hematoxylin-eosin and examined in a “blind-fashion” manner. 
In particular, we aimed to evaluate bronchiolar epithelial changes 
and peribronchiolar inflammation in large, medium, and small or 
terminal bronchioles, as well as inflammatory changes in alveoli. 
In the lung, bronchointerstitial pneumonia intensity was assessed 
by means of a semi-quantitative lesion score. The pathological 
scores for tracheal and pulmonary tissues were as follows: 0: no 
lesions, 1: mild lesions, 2: moderate lesions, 3: severe lesions.
Virus Detection in BalF
In order to check IV replication in the lower respiratory tract 
of pigs, BALF samples collected from pigs killed at day 3, 6, 
and 21 were tested for gene M of the influenza A virus using a 
quantitative real-time PCR procedure (17). The sensitivity of 
the test was equal to 102 tissue culture infectious doses 50% 
(TCID50)/25 microliters.
serum antibody
Anti-influenza A virus nucleoprotein (NP) antibody levels 
were investigated in serum using the ID Screen® Influenza A 
Antibody Competition ELISA (ID-Vet, France) following the 
manufacturer’s instructions at days 0, 6, and 21 p.i. as previously 
described (14). The threshold level was set at <50% of the OD 
level observed in the control wells without any swine serum. 
The kit detects antibodies against all Influenza A subtypes and 
antigenic variants thanks to the use of a monoclonal antibody 
against a highly conserved epitope of the Influenza A virus NP 
and it was used with pig serum as previously described (13, 14) 
to avoid background.
clinical immunology Parameters and 
cytokines in BalF
Acute phase proteins (APP) of pigs (Haptoglobin and Serum 
Amyloid A, SAA) were investigated in BALF samples by com-
mercial colorimetric kits (Haptoglobin kit, Tridelta Development, 
code TP801. Multispecies SAA ELISA Kit, Tridelta Development, 
code TP802), according to the manufacturers’ directions.
Interferon-alpha was measured in BALF samples by two 
different assays. First, a sandwich ELISA with monoclonal 
antibodies (mAb) F17 and K9 to porcine IFN-alpha1 was used 
as previously described (18). IFN-alpha was also measured by a 
cytopathic effect inhibition assay on MDBK cells with vesicular 
stomatitis virus (19). The test was calibrated with a preparation 
of porcine recombinant IFN-α1 (PBL Biomedical Laboratories, 
cat. 17100-1). The units of this preparation are determined with 
respect to the international reference standard for human leuko-
cyte IFN (Ga-902-530) provided by National Institutes of Health 
(Bethesda, MD, USA). This assay for porcine IFN-α in serum had 
been also validated in a previous study (20). Identification of the 
cytokine was performed by a neutralization assay on MDBK cells 
of IFN α-positive BALF samples (21), using monoclonal antibody 
(mAb) G16 to porcine IFN-α1 (Serotec, cat. MCA1935Z). The 
assay was calibrated with porcine recombinant IFN-α1.
Interleukin-6 and TNF-α were determined in BALF samples 
by bioassays on 7TD1 and WEHI 164 cells, respectively, as 
previously described (22, 23). Cytokine concentrations were 
determined from a standard curve created with reference prepa-
rations of human recombinant IL-6 and TNF-α (Pierce Endogen, 
Rockford, IL, USA).
Flow cytometry
Immunophenotyping of BALF cells was carried out by flow 
cytometry. This was performed using indirect labeling of cells by 
hybridoma supernatants for CD3 (clone PPT3), CD172a (SWC3) 
(clone 74-22-15a), and Swine MHC (SLA) II (clone 1F12) (24). 
The antibody against γδ TcR (clone PGBL22A) was purchased 
from Euroveterinaria S.A. and the one against CD4 (clone 
74-12-4) was purchased from Serotec S.A., both conjugated 
with R-Phycoerythrin (PE). As for the hybridoma supernatants, 
the concentration of antibody was empirically calculated after 
titration of each preparation and the secondary antibodies were 
either PE or APC-conjugated goat anti-mouse IgG (Jackson 
ImmunoResearch, Suffolk, UK) used following the manufactur-
er’s instructions. Each primary antibody was compared with its 
relevant isotype control in each sample using the same concentra-
tions. Briefly, 2.5 × 105 cells/50 μl/well were labeled for 1 h at 4°C 
with 50 µl of each monoclonal antibody (relevant and irrelevant) 
at a pre-established, optimal dilution. After 1-h incubation at 4°C, 
cells were washed with cold PBS with 2% FCS by centrifugation at 
450 × g, 4°C, 5 min. Then, the secondary antibody conjugated to 
R-Phycoerythrin diluted 1:200 was added. Cells were incubated 
for a further 1 h at 4°C, then washed as before and resuspended 
in PBS with 2% FCS. Stained cells were acquired using FACSaria I 
(Becton Dickinson®) and analyzed by software FACSDiva v.6.1.2. 
A gating strategy was applied to living cells using their forward 
and side scatter (FS/SS) characteristics. Staining with isotype 
controls did not exceed 1% in all the samples.
Quantitative real-time Pcr assays for 
cytokine genes
Total RNA was extracted from BALF cells using RNeasy Mini 
Kit (Qiagen, Milan, Italy) by the Qiacube System (Qiagen, Milan, 
Italy) in accordance with the manufacturer’s instructions. The 
protocol included a DNAse treatment for eliminating genomic 
DNA. RNA concentration was evaluated by UV absorbance 
(Biophotometer, Eppendorf, Milan). Three µl of RNA (10 ng/µl) 
were added to the reaction mix for cDNA synthesis. This was 
TaBle 1 | Oligonucleotide primer sequences for evagreen qrT real-time Pcr amplification of porcine genes.
gene Protein Primers geneBank accession number
Interleukin (IL)-8 Porcine IL-8 F: 5′-TTCGATGCCAGTGCATAAATA-3′ AB057440.1
R: 5′-CTGTACAACCTTCTGCACCCA-3′
IL-10 Porcine IL-10 F: 5′-AGCCAGCATTAAGTCTGAGAA-3′ AM295341
R: 5′-CCTCTCTTGGAGCTTGCTAA-3′
IL-1β Porcine IL-1β F: 5′-AATTCGAGTCTGCCCTGTACCC-3′ NM_001005149
R: 5′-GCCAAGATATAACCGACTTCACCA
Tumor necrosis factor (TNF)-α Porcine TNF-α F: 5′-TGCCTACTGCACTTCGAGGTTATC-3′ NM_214022.1
R: 5′-GTGGGCGACGGGCTTATCTG-3′
IFNA5/6 Porcine interferon (IFN)-α5/6 F: 5′-GCACAAATGAGGAGAATATCT-3′ DQ872658.1
R: 5-CCTCCTGAGTCTGTCTTG-3
IFNA7/11 Porcine IFN-α7/11 F: 5′-GGGACTTTGGATCCCCTCAT-3′ GQ415065.1
R: 5′-GTGGAGGAAGAGAAGGATG-3′
IFNA9 Porcine IFN-α9 F: 5′-GTGCTGCTCAGCTGCAAG-3′ GQ415063.1
R: 5′-AGTCCTCCTCCAGCAGGGGC-3′
IFNA13 Porcine IFN-α13 F: 5′-ATCCTCAGCCCTCCTCAC-3′ NM_001164843.1
R: 5′-ATCCAAAGTCCCTTCTGT-3′
IFNA16 Porcine IFN-α16 F: 5′-GTTCAGACCCACAGCCTG-3′ NM_001164855.1
R: 5′-TCCTCCTGAGTCTGTCTTGC-3′
Beta2-microglobulin Sus scrofa, beta-2-microglobulin F: 5′-CGCCCCAGATTGAAATTGATTTGC-3′ AB436775.1
R: 5′-GCTATACTGATCCACAGCGTTAGG-3′
IFNB Porcine IFN-β F: 5-AGTTGCCTGGGACTCCTCAA-3′ JN391525.1
R: 5-CCTCAGGGACCTCAAAGTTCAT-3′
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performed in the presence of Random Hexamers as previously 
described (25). Then, the expression of porcine IFN-α, IL-8, 
IL-6, IL-1β, and TNF-α genes was determined using the primer 
sets shown in Table 1. The choice of the porcine IFN-α subtypes 
shown in Table 1 was dictated by their important role in constitu-
tive expression of type I IFNs (26) and, therefore, by their possible 
expression before IV infection. Porcine beta2-microglobulin was 
used as housekeeping control gene (Table  1) to normalize the 
test results at different sampling times. EvaGreen real-time PCR 
amplification was performed over 40 cycles in a CFX96 real-time 
system (Bio-Rad, Milan, Italy) as described by Razzuoli et  al. 
(27). In each sample, the relative expression of the selected genes 
was calculated using the formula ΔCt = Ct (target gene)—cycle 
threshold (Ct) (housekeeping), where Ct (cycle of threshold) 
values were the mean of three test replicates ±1 SD, as previously 
described (28). Negative samples were given a Ct 40 fictitious 
value for further statistical examination.
statistical analyses
Gene expression data (ΔCt values) obtained on BALF cells were 
checked for normality by the Kolmogorov–Smirnov test. The 
data sets passing the normality test were checked for significant 
differences between time points (days 3, 6, 21 p.i.) by one-way 
ANOVA for unpaired data, whereas the others were evaluated by 
the non-parametric Kruskal–Wallis procedure (GraphPad Prism 
5.03, GraphPadSoftware, San Diego, CA, USA). The threshold for 
significance was set at P < 0.05.
Statistical analyses on flow cytometry data were carried out 
using the SAS system V.9.1.3 (SAS institute Inc., Cary, NC, USA). 
For all analyses, the individual pig was used as the experimental 
unit. Shapiro Wilk’s and Levene tests were used to evaluate the 
normality of the distribution of the continuous variable and the 
homogeneity of variances, respectively. A statistical analysis was 
performed to study the association between the different vari-
ables with the different experimental groups at the different time 
points (0, 3, and 21 days post-infection). To analyze the associa-
tion between continuous, normally distributed variables and the 
different experimental groups, an ANOVA test was used at 0, 3, 
and 21 days post-infection. Finally, a Wilcoxon rank-sum test was 
used for the continuous, non-normally distributed variables at 
the different time points.
resUlTs
clinical and Postmortem Findings
No clinical signs were shown during the experimental pro-
cedure, such as fever, weight loss, anorexia, depression, nasal 
discharge, or altered breathing. Temperature was not higher 
than 40.5°C in any animal at any time point. There were no 
traumatic lesions as a result of intratracheal virus inoculation. 
Gross lesions were mostly shown by animals infected with the 
swine IV, but some lesions were also detected in lungs from pigs 
infected with other IV strains. Pulmonary lesions (Table  2) 
were consistent with bronchointerstitial pneumonia at different 
TaBle 2 | Macroscopic lesions observed in controls and pigs inoculated 
with different iVs.
Days p.i. Mock swine iV equine iV canine iV avian iV seal iV
3 0 (0) 2.5 (0.6) 0.3 (0.5) 0.3 (0.5) 1.0 (0.8) 1.5 (1)
6 0 (0) 2.0 (0.8) 0.5 (0.6) 0.3 (0.5) 1.0 (0.5) 1.3 (1.3)
21 0 (0) 1.0 (0.8) 0.5 (0.6) 0.5 (0.6) 0.5 (0.6) 0.5 (0.6)
Macroscopic lesions observed in mock and IV-infected pigs. Gross lesions were 
classified depending on the extension of pneumonia (0–3). Data represent the average 
for each group; SD is shown in brackets.
0 = absence of lesions, 1 = mild lesions, 2 = moderate lesions, 3 = severe lesions.
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grades of severity (0–3). The pigs infected with Swine IV pre-
sented the highest level of severity followed by those infected 
with Seal IV, Avian IV, and either Equine or Canine IV in 
descending order.
histopathology
Results are shown in Figure  1. Nasal turbinates sections did 
not differ between IV and mock-infected animals. Tracheal 
lesions of IV-infected pigs consisted of variable grades (0–3) 
of lymphoplasmacytic infiltration in the lamina propria. In 
the most severe cases, focal ulceration of the mucosa with 
fibrin deposition and neutrophilic infiltration was observed. A 
lymphoplasmacytic infiltration was observed in the bronchioli 
with extension to surrounding alveolar septa. In the most 
severe cases, at day 3 p.i., necrosis of the bronchiolar epithe-
lium was observed with accumulation of necrotic cells in the 
bronchiolar lumen and alveolar spaces. In agreement with the 
gross lesion scores shown in Table 2, histopathological lesions 
were much more severe in pigs of the Swine group at day 3 p.i. 
followed by the animals infected with Seal or Avian IV. The 
pigs infected with either Equine or Canine IV showed the least 
severe lesions (Table 3).
iV infection
To confirm the virological data (IV titration in embryo-
nated chicken eggs) shown in our previous paper (16), viral 
replication was evaluated by quantitative real-time PCR on 
BALF samples of animals sacrificed at days 3, 6, and 21 p.i. 
(Figure  2). The swine-adapted IV actively replicated in the 
pig respiratory tract at both day 3 and 6 p.i., as shown by Ct 
values ranging from 21 to 33. Instead, we could detect only 
one IV-positive BALF sample in the Equine group at day 3 p.i. 
with a Ct value of 35 and none in the Canine group, indicating 
very little replication of those viruses. On the contrary, the 
Avian and Seal virus strains showed a moderate replication at 
day 3 in most pigs, with Ct values ranging from 33 to 37. One 
animal from the Seal group was still IV-positive at day 6 p.i. 
with a Ct value of 37. The above PCR data are in agreement 
with IV titrations in embryonated chicken eggs, reported in 
our previous paper (16).
antibody response
Total anti-NP antibody levels were measured by a competition 
ELISA kit in serum samples from all animals at the beginning of 
the assay (day 0), days 6, and 21 p.i. All animals were seronegative 
at the beginning of the experiment (day 0, Figure 3). Also, no 
antibody response was observed in mock-infected animals. On 
the other hand, all IV-infected animals seroconverted (OD < the 
threshold) by day 21 p.i. Most of them seroconverted by day 6 p.i. 
in groups infected with Swine, Avian, and Seal viruses, whereas 
the response was delayed in groups infected with the Equine and 
Canine viruses (Figure 3).
innate immune responses
The above findings confirmed a different invasiveness in pigs of 
swine-adapted and non-adapted IV strains in terms of virus rep-
lication and pathological lesions. On this basis, we investigated 
innate immune responses during IV infection in the respiratory 
tract that might differ between pathogenic and non-pathogenic 
IV strains in pigs.
Protein cytokine levels were measured in all animals from 
all groups by different assays. Firstly, levels of IFN-α in BALF 
were analyzed by ELISA. All samples were negative except those 
collected from animals infected with Swine IV at day 3 p.i. 
(Figure  4A). These findings were confirmed by a bioassay for 
type I IFN on MDBK cells, and the specificity of the response 
was confirmed by an IFN-neutralization assay based on a mAb 
to porcine IFN-alpha 1 (data not shown).
There was only one pig (Sw-2) with a slight TNF-α response 
in BALF at day 3 p.i. in the Swine IV-infected group. BALF 
samples were always TNF α-negative in the other groups (data 
not shown).
On the other hand, IL-6 was clearly detected at day 3 p.i. in 
the BALF samples of Swine IV-infected pigs. In the other groups, 
there was no significant difference with respect to mock animals, 
with the exception of pig Se-4 in the Seal group (day 3 p.i.) 
(Figure 4B).
The high IL-6 response in BALF of the Swine group at 
day 3 p.i. led us to investigate haptoglobin and SAA in BALF 
samples of the Mock, Swine, and Equine groups at day 3 p.i. 
All the samples were haptoglobin-negative (<0.01 mg/ml). On 
the contrary, all the Equine IV-infected pigs were SAA-positive 
(range: 2.9–5.8  mg/ml), as also was one sample of the Swine 
group (4.7  mg/ml). All the other samples were SAA-negative 
(<0.01 mg/ml).
cytokine gene expression studies
The expression of some cytokine genes was investigated by 
quantitative real-time PCR on BALF cells. Results are shown in 
Figure  5 and detailed hereunder. MOCK group: there was no 
significant difference between the different sampling times for 
each cytokine gene under study. SWINE group: there was no 
significant difference of gene expression at the three time points. 
Only tendencies (P <  0.10) were shown for IL-8, IL-10, and 
IFN-gamma genes. EQUINE group: significant differences were 
shown for IFNA9, IFN-gamma, and IL-10 genes. In particular, 
at day 21 p.i., an increase was observed of IFN-gamma and 
IL-10 and a decrease of IFNA9 gene expression. CANINE group: 
significant differences were shown for IFNA5/6, IFNA7/11, and 
IFN-gamma genes. At day 6 p.i., there was a downregulation of 
IFNA5/6 and 7/11, as opposed to a significant increase of IFN-
gamma gene expression at day 21 p.i. No other significant change 
of expression was detected. AVIAN group: there were significant 
TaBle 3 | histopathological analyses of tracheal and lung tissues from mock and iV-infected pigs.
Days p.i. Mock swine iV equine iV canine iV avian iV seal iV
T l T l T l T l T l T l
3 0 (0) 0 (0) 1.5 (1) 2.3 (0.5) 0.3 (0.5) 0.5 (0.6) 0.3 (0.5) 0 (0) 1.3 (0) 2 (0.8) 1 (1.2) 1.8 (1.5)
6 NP NP 1.5 (0.5) 0.3 (1.3) NP NP NP NP 1.3 (0.5) 0.5 (0.6) 1.5 (1.3) 0.5 (1)
21 NP NP 0 (0) 0 (0) NP NP NP NP 0.8 (0.5) 0.8 (0.8) 0.3 (0.5) 1.3 (0.6)
T, trachea; L, lung, NP, not performed.
For each tissue, the pathological score varied from 0 to 3; data represent the average for each group (4 and 2 animals in IV and mock groups, respectively); the SD is shown in 
brackets.
FigUre 1 | histopathological analysis of lungs of pigs, at day 3 after infection with different iVs. (a) Negative control; (B) swine IV, moderate to severe 
inflammation of the bronchioli and surrounding alveoli (bronchointerstitial pneumonia); (c) equine IV, no significant lesions; (D) canine IV, no significant lesions; 
(e) avian IV, moderate bronchointerstitial pneumonia; (F) seal IV, mild to moderate bronchointerstitial pneumonia.
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differences for IFNA5/6, IFNA13, IFNA16, and IFN-gamma 
gene expression and tendencies for IFNA7/11 and IFNA9 genes. 
In particular, a downregulation of these genes occurred at day 
6 p.i. SEAL group: IFNA5/6 was downregulated at day 21 p.i., 
whereas IFN-gamma and IL-10 genes were upregulated at the 
same time.
immunophenotyping of leukocytes
Based on the fact that local responses in BALF from Swine 
IV-infected animals were different from those of the other 
IV-infected pigs, we investigated whether there was any difference 
in cells infiltrating the lungs of infected pigs (Figure 6). Therefore, 
cells from BALF were analyzed by flow cytometry to detect changes 
among animals of each group. Swine IV-infected animals had 
significantly more T cells (CD3+) at day 3 and 6 p.i. than the rest 
of the infected groups (P < 0.05), and the highest concentrations 
also corresponded to the appearance of a low concentration of the 
γδ T cell receptor phenotype. At day 3 p.i., γδ T cell percentages 
were significantly different from those of the other infected pigs 
(P < 0.05). Also, only Swine IV-infected animals showed a clear 
increment of pDCs (defined as CD172a + CD4 + cells) at day 6 
p.i., with a statistical tendency (P = 0.06). No major changes were 
detected concerning the surface expression of SLA-II or CD172 
in BALF cells (data not shown).
DiscUssiOn
In this study, the pathogenicity of IV strains with different 
host specificity was characterized in swine in terms of clinical 
symptoms and tissue lesions. Also, we aimed to define a possible 
association between innate immune responses to IV strains, and 
clinical and postmortem findings.
The main findings of our study are outlined in Table  4. 
Despite wide variations among individual pigs, the IV strains 
under study could be discriminated in terms of pathogenicity. 
Our results confirmed a widely different replication of IV strains 
in the lower respiratory tract of swine: the swine-adapted virus 
replicated to a large extent, as opposed to the other IV strains 
under study. These PCR results were fully in agreement with 
virus titration results in our previous study (16). Interestingly, 
the avian and seal H3N8 strains replicated more than the equine 
and canine strains. Replication of the canine and equine strains 
could have transiently taken place at days 1–2 post infection, 
before the first sampling. This is consistent with low-grade 
FigUre 3 | antibody responses to different iV strains were investigated by means of a competition elisa for the nucleoprotein antigen. The Y axis 
indicates the percentage of OD with respect to the control reaction without any serum (100%). The horizontal dashed line corresponds to the test threshold, i.e., 
50% of the control OD value. Ab-positive sera show percentage values beneath the threshold. The X axis indicates the pigs under study at three sampling days p.i. 
(0, 6, 21). Mo, mock-infected; Sw, swine IV-infected; Eq, equine IV-infected; Ca, canine IV-infected; Av, avian IV-infected; Se, seal IV-infected. Samples from day 0 
are shown as white bars, from day 6 p.i. as gray bars, and from day 21 p.i. as black bars.
FigUre 2 | results obtained by rT real-time Pcr for iV M gene on bronchoalveolar fluids samples collected from mock and iV-infected pigs. Positive 
samples are shown as cycle threshold number in real-time PCR. PCR-negative samples corresponded to Ct ≥ 40, and they are not shown in the graph. Two and 
four pigs were present in each mock and IV-infected group, respectively. Samples from day 3 p.i. are shown as gray bars and from day 6 p.i. as striped bars. All day 
21 samples (black bars in the legend) were PCR-negative.
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postmortem lesions and histopathological analyses on samples 
at day 3 p. i., as reported in Tables 2 and 3. These findings high-
light different invasiveness of Swine, Seal and Avian, Equine, and 
Canine viruses, in descending order (Figure 2). The replication 
to a higher level of Swine, Avian, and Seal IV was associated 
with an earlier antibody response compared with groups Equine 
and Canine (Figure 3), where a possible low-titered replication 
could account for the late antibody response to NP. Also, we 
cannot rule out that defective or partially assembled particles 
in the viral inoculum could also have induced antibodies to NP, 
and that different IV strains could elicit antibodies with different 
reactivity in the assay. Please notice, however, that amino acid 
identity of NPs with respect to swine-adapted IV was very high, 
ranging between 92% (canine strain) and 97% (avian and seal 
strains). Therefore, the combination of an Ab response to IV NP 
with macro and microscopic lesions and the clear discrimination 
from mock-infected animals indicate that pigs can be produc-
tively infected by H3N8 viruses, which is also in agreement with 
the replication of both seal and avian H3N8 strain in tracheal 
explants (16).
FigUre 4 | (a) Interferon (IFN)-α was investigated in bronchoalveolar fluids 
(BALF) samples of Swine IV-infected pigs at day 3 p.i. by sandwich ELISA 
with monoclonal antibodies F17 and K9 to porcine IFN-α1. Results are 
shown in terms of Units/ml (mean + 1 SD) on the basis of a standard curve 
created with porcine recombinant IFN-α1. IFN-α titers <1 U/ml were the 
baseline in our assays. The BALF samples of mock and all other IV groups 
were always IFN α-negative at all the time points. (B) Interleukin (IL)-6 was 
measured in BALF samples by a bioassay on IL 6-dependent 7TD1 
hybridoma cells. On the basis of both final number and viability of 7TD1 cells, 
IL-6 concentration was determined from a standard curve created with a 
reference preparation of human recombinant IL-6 (Pierce Endogen, Rockford, 
IL, USA). Results are shown in terms of group average +1 SEM. The IL-6 
concentration in the swine group at day 3 p.i. is significantly different 
(one-way ANOVA, P < 0.05). Please notice that the result of the Seal group 
at day 3 p.i. was accounted for by an outlier and three non-responder pigs. 
Samples from day 3 p.i. are shown as gray bars, from day 6 p.i. as striped 
bars, and from day 21 p.i. as black bars.
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Most importantly, the pathogenic role of swine-adapted IV 
strain was confirmed by both gross and histological lesions in 
lungs, not induced by the other viruses under study. In turn, the 
presence of lesions could be temporarily associated with local 
innate immune responses in the lower respiratory tract (BALF 
samples): IFN-α and IL-6 (Figure 4). These findings are in agree-
ment with those of other experimental infections of pigs with IVs 
(5, 6). Moreover, previous results in our group showed that IFN-
α secretion was only detected in  vitro when Swine IV-infected 
myeloid porcine DCs but not when other IVs from human or 
avian origin were used (15). Interestingly, the IFN-α titers in 
BAL fluids of swine IV-infected pigs were not associated with the 
expression of IFN-α genes, in agreement with our previous data 
in vitro (25) and another study in vivo (29).
But for one animal, the IL-6 local response in BALF samples of 
the Swine group at day 3 p.i. was not in agreement with the pres-
ence of APP. Unexpectedly, SAA was clearly expressed in BALF 
samples of the Equine group at day 3 p.i. This indicates that SAA 
responses can be induced despite poor virus replication in the 
lower respiratory tract. Also, the Equine strain widely affected 
the expression of cytokine genes (see Figure 5). This result sug-
gests that innate immune responses can be triggered by some IV 
strains regardless of their replication efficiency. Also, our findings 
confirm the possible extrahepatic expression of APP observed in 
other disease models (30).
The Swine IV strain also caused detectable changes of the 
BALF-infiltrating leukocyte populations. In particular, some 
CD4+CD172a+ cells were observed in BALF from Swine 
IV-infected animals but not in BALF from the other IV groups. 
These are considered pDCs in swine (31), and their main 
function is the release of high levels of type I IFNs. This is in 
agreement with the fact that IFN-α was only observed in BALF 
samples of the Swine IV-infected group (Figure  4A). IFN-α 
was detected at day 3 p.i., whereas the increased prevalence 
of pDCs was detected at day 6 p.i. This apparent discrepancy 
could be explained by our detection limit for pDCs in BALF, as 
a certain minimum concentration would probably be required 
for detection by flow cytometry. Also, we do not rule out a dis-
tinct or overlapping release of IFN-α by alveolar macrophages 
or other cells (e.g., epithelial cells) at an early time point after 
infection.
Despite the lesions caused by the Swine IV strain, no disease 
signs were observed. This result is in contrast with an experimen-
tal infection of pigs with a Danish H1N2 IV strain, which led to 
the development of typical clinical signs of influenza (29). The 
absence of clinical signs was probably associated in our study 
with the reduced infectious challenge (2 × 105 EID50), which was 
necessary to standardize the challenge infection with IV strains 
showing high or poor replication in embryonated chicken eggs 
(16). Yet, our data are in agreement with the fact that many pigs 
become infected with one or more IV subtypes without showing 
clinical signs (32).
The gene expression data point at a crucial neglected issue: IV 
strains seem to cause a long-term regulation of the innate immune 
response, by far beyond the actual period of virus replication and 
persistence in organs and tissues. Instead, the modulation of 
cytokine genes was more related to tissue damages, as indicated 
by the gross and hystopathological lesions persisting in some pigs 
until day 21 p.i.
Retrospectively, earlier sampling of lung tissues and/or BALF 
samples could have provided a more clear picture of cytokine 
gene expression levels, which were probably in a descending 
phase at day 3 p.i. after a possible major peak at day 1 (29). This 
is particularly true of IFN-β, which is highly up-regulated for a 
short time after IV infection (29). Indeed, our previous results 
actually showed that IFN-β gene upregulation was only detected 
8 h after Swine IV infection of myeloid porcine DCs in vitro (15). 
This is also in agreement with its role as immediate-early type I 
IFN gene in non-lymphoid cells (33).
Some innate immune responses were triggered by the swine-
adapted IV strain, only. Diverse IV strain-specific factors could 
account for these responses, such as hemagglutinin receptor speci-
ficity and affinity, polymerase efficiency and activity of IV anti-IFN 
proteins, which may show additive or synergistic interactions with 
FigUre 5 | rT real-time Pcr for some cytokine genes was carried out on bronchoalveolar fluids cells collected at the indicated times after 
infection. For each sample, the relative expression of the selected genes was calculated using the formula ΔCt = Ct (target gene)—cycle threshold (Ct) 
(housekeeping), where Ct values were the mean of three test replicates. Results are shown as n-fold change in gene expression (2−ΔCt). The same superscripts (a, b, 
c) on the bar indicate significant differences (P < 0.05) in one-way ANOVA or Kruskal–Wallis test. Samples from day 3 p.i. are shown as gray bars, from day 6 p.i. as 
striped bars, and from day 21 p.i. as black bars.
9
Montoya et al. Innate Immune Responses to IVs
Frontiers in Veterinary Science | www.frontiersin.org April 2017 | Volume 4 | Article 48
the host’s immune system. On the basis of our previous results on 
tracheal explants of pigs (16), components other than affinity for 
sialic acid receptors of Swine IV strains are likely to account for 
high innate immune responses. In particular, gross and histologi-
cal lesions are probably induced following recognition of PAMPs 
of the swine-adapted IV strains and activation of the NLRP3 
inflammasome (cryopyrin) (34). Such a response is probably 
less intense after infection with other IV strains, which can be 
accounted for by different causes: (A) amino acid changes of some 
viral PAMPs. (B) Suppressive regulations by ODNs of non-swine 
IV strains [as shown, e.g., for Porcine Circovirus 2 (35), and/or by 
IFN-α subtypes with anti-inflammatory control activity (36)]. (C) 
Third, the innate immune response to the swine-adapted IV could 
be simply due to the much higher and/or quicker replication of 
this strain. In this respect, viral replication measured by quantita-
tive real-time PCR correlated with the degree of lesions. Beyond 
the above hypotheses, a biological explanation of the observed 
results could be obtained by reverse genetics studies: changes or 
disruptions should be engineered in the viral genome, and effects 
of such alterations should be checked in vitro or in vivo.
On the whole, the emerging picture outlines a host/virus rela-
tionship characterized by a strict control of the innate immune 
responses of pigs to non-adapted IV strains. The swine-adapted 
ones can circumvent these controls, in the framework of a rapid, 
effective, non Ab-dependent containment of the primary virus 
infection in the lower respiratory tract. Interestingly, the uncompli-
cated exposure to the Swine IV strain did not induce clinical signs 
in our study. This finding points at a crucial role of the infectious 
pressure caused by common pathogens on farm for disease onset. 
This feature probably exerts additive and/or synergistic effects 
with common environmental stressors (animal density, seasonal 
changes, hierarchy fights after commingling) and genetic traits. As 
FigUre 6 | continued
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TaBle 4 | Main findings of experimental iV infection in pigs.
iV 
strains
Modulation of cytokine gene expression in 
bronchoalveolar fluids (BalF) cellsb
histopathological 
lesions
replication 
in lungs 
(Pcr)
ab 
response
interferon 
(iFn)-α in 
BalF
interleukin 
(il)-6 in 
BalF
saa 
in 
BalF
BalF: cell 
infiltrates
iFn a5/6 iFn 
a7/11
iFn 
a9
iFn 
a13
iFn 
a16
iFn-γ il-10
Mock − − − − − −
Sw ++ ++ ++ ++ ++ ± ++a
Eq ± ± + − − ++ − + + +
Ca ± − + − − − + + +
Av + + ++ − − − + + + +
Se + + ++ − − − + + +
aCD3 T cells, γδ T cells, plasmacytoid dendritic cells, as evaluated by flow cytometry.
bBased on ΔCt values at each time point.
FigUre 6 | immunophenotyping of pig bronchoalveolar fluids (BalF) cells after mock and iV-infection. BALF cells of pigs were submitted to 
immunophenotyping at the indicated times after mock or IV infection. Results are expressed in terms of percent marker-positive cells out of 10,000. (a) Gating 
strategy for flow cytometry. Positive cells were considered as the percentage within the black circle in each plot as compared with each isotype control.  
(B) Percentage of CD3-positive T cells. (c) Percentage of CD172-CD4, double-positive cells. (D) Percentage of γδ T cells. Samples from day 3 p.i. are shown as 
gray bars, from day 6 p.i. as striped bars, and from day 21 p.i. as black bars.
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a result, fundamental components of the innate immune response 
would be affected, and clinically overt influenza outbreaks could 
take place on farm with full-blown clinical pictures.
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